Form 4: Insider Reports Transfers of INBP Common Stock

William H. Milmoe, a Director and 10% owner of Integrated Biopharma Inc., reported transfers of common stock between related entities.

Summary

• William H. Milmoe, a Director and 10% owner of Integrated Biopharma Inc. (INBP), filed a Form 4 to report changes in beneficial ownership.
• On March 24, 2026, 1,356,293 shares of Common Stock were transferred from CD Financial, LLC to CDDS 2.0, LLC, an entity controlled by Damon DeSantis.
• On the same date, an additional 7,392 shares of Common Stock were transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC.
• Both transfers were reported with a transaction price of $0, indicating a non-sale transfer.
• Following these transactions, Milmoe's indirect beneficial ownership of INBP Common Stock is 11,505,340 shares.
• This total includes 9,116,547 shares owned by CD Financial, LLC, 2,235,417 shares owned by the Carl DeSantis Revocable Trust, 14,709 shares owned by the Estate of Carl DeSantis, and 138,667 shares owned directly by Milmoe.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Form 4 filings reporting internal transfers between related entities typically do not indicate a change in the company's operational or financial performance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insiders reporting changes in their beneficial ownership, providing transparency into how key personnel and significant shareholders manage their holdings. These specific transfers appear to be internal reorganizations among related entities rather than market-driven transactions.

Related Party Transactions

• Transfer of 1,356,293 shares from CD Financial, LLC to CDDS 2.0, LLC, an entity controlled by Damon DeSantis.
• Transfer of 7,392 shares from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, an entity controlled by Damon DeSantis.
• William H. Milmoe, the reporting person, has indirect beneficial ownership in CD Financial, LLC and the Carl DeSantis Revocable Trust.

Stakeholder Impact

• Shareholders: No direct impact on the total outstanding shares or market liquidity. The transfers represent a reorganization of beneficial ownership among related parties.
• Management: Reflects internal asset management decisions by a director and significant shareholder.

Key Dates

Keywords

Integrated Biopharma, INBP, Form 4, Insider Transaction, Beneficial Ownership, Stock Transfer, William Milmoe, Damon DeSantis, CD Financial, Carl DeSantis Revocable Trust